Clinical Trial Update: Re-boosting of HIV-1 Infected Subjects With Vacc-4x [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating re-boosting HIV-1 infected subjects with Vacc-4x. Results for this study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Vacc-4x

Snippet

Sponsor: Bionor Immuno AS | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2017-03-06